Li Yuanjiaozi, Sakamoto Michiharu, Sawaragi Eiichi, Nakano Takashi, Katayama Yasuhiro, Yamanaka Hiroki, Tsuge Itaru, Morimoto Naoki
Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Plast Reconstr Surg Glob Open. 2022 Nov 3;10(11):e4636. doi: 10.1097/GOX.0000000000004636. eCollection 2022 Nov.
A micrograft (MG) suspension produced by the Rigenera protocol has been used to stimulate tissue regeneration. Recently, a combination therapy of an artificial dermis and skin MG has been used to promote angiogenesis and granulation tissue formation in the artificial dermis. There are no reports comparing the differences in MG impregnation efficiency between different artificial dermis products. Therefore, we compared the impregnation of skin MG in Pelnac Gplus and Integra.
Skin MG was prepared from the skin of C57BL/6JJcl mice using Rigeneracons and administered onto Pelnac Gplus and Integra sheets. The amount of MG suspension impregnated in Pelnac Gplus and Integra was evaluated. Pelnac Gplus and Integra sheets combined with MG were applied to murine defects, and wound area, neoepithelium length, granulation tissue formation, and newly formed capillaries were compared with the control groups on days 7 and 14.
The weight percentage of the MG absorbed by Pelnac Gplus and Integra was 88.8% ± 3.5% and 28.2% ± 7.0%, respectively ( < 0.05). In the in vivo experiment, the area of newly formed granulation tissue and both the number and area of newly formed capillaries in the PelnacG + MG group were significantly larger than those in the control group at 14 days after implantation ( < 0.05).
Skin MG was successfully impregnated into Pelnac Gplus by simple administration but not into Integra. Administration of skin MG into the Pelnac Gplus promoted granulation formation and angiogenesis. Pelnac Gplus was more suitable than Integra in the combination therapy.
通过Rigenera方案制备的微移植(MG)悬浮液已用于刺激组织再生。最近,人工真皮与皮肤MG的联合疗法已被用于促进人工真皮中的血管生成和肉芽组织形成。尚无关于不同人工真皮产品之间MG浸渍效率差异比较的报道。因此,我们比较了皮肤MG在Pelnac Gplus和Integra中的浸渍情况。
使用Rigeneracons从C57BL/6JJcl小鼠的皮肤制备皮肤MG,并将其施用于Pelnac Gplus和Integra片材上。评估Pelnac Gplus和Integra中浸渍的MG悬浮液的量。将与MG结合的Pelnac Gplus和Integra片材应用于小鼠缺损处,并在第7天和第14天与对照组比较伤口面积、新上皮长度、肉芽组织形成和新形成的毛细血管。
Pelnac Gplus和Integra吸收的MG重量百分比分别为88.8%±3.5%和28.2%±7.0%(<0.05)。在体内实验中,植入后14天,PelnacG+MG组新形成的肉芽组织面积以及新形成的毛细血管数量和面积均显著大于对照组(<0.05)。
通过简单给药,皮肤MG成功浸渍到Pelnac Gplus中,但未浸渍到Integra中。将皮肤MG施用于Pelnac Gplus可促进肉芽形成和血管生成。在联合治疗中,Pelnac Gplus比Integra更合适。